---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-029935"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2022-11-15T23:59:59+00:00"
generated_at: "2026-06-21T18:47:15.320006+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# Oncology Institute announces Q3 2022 results and FY2022 guidance via slide deck

## Summary
- Slide presentation includes financial results for three and nine months ended Sept 30, 2022.
- Company provided updated business guidance for the year ending Dec 31, 2022.
- Presentation issued on Nov 15, 2022; common stock (TOI) and warrants (TOIIW) traded on Nasdaq.

## SEC filing metadata
- accession: 0001628280-22-029935
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2022-11-15T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000162828022029935/0001628280-22-029935-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000162828022029935/toi-20221115.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-029935
- JSON: https://secwatch.observer/filing/0001628280-22-029935.json
- Plain text: https://secwatch.observer/filing/0001628280-22-029935.txt

## Key facts
- Earnings Releases
  Oncology Institute, Inc. reported financial results for three and nine months ended September 30, 2022.
  - Period: three and nine months ended September 30, 2022
  - Result: reported results
  source text: Item 2.02. Results of Operations and Financial Condition On November 15, 2022, The Oncology Institute, Inc. (the "Company") issued a slide presentation which includes the Company's financial results for the three and nine months ended September 30, 2022 and certain other financial information. A copy of the presentation is furnished hereto as Exhibit 99.1, which are incorporated by reference herein.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000162828022029935/0001628280-22-029935-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.